Neuronal Deposition of Amyloid-β Oligomers and Hyperphosphorylated Tau Is Closely Connected with Cognitive Dysfunction in Aged Dogs.

Alzheimer’s disease Aβ1 - 42 oligomers amyloid-β plaques canine cognitive dysfunction hyperphosphorylated tau

Journal

Journal of Alzheimer's disease reports
ISSN: 2542-4823
Titre abrégé: J Alzheimers Dis Rep
Pays: Netherlands
ID NLM: 101705500

Informations de publication

Date de publication:
2021
Historique:
accepted: 30 08 2021
entrez: 6 12 2021
pubmed: 7 12 2021
medline: 7 12 2021
Statut: epublish

Résumé

Canine cognitive dysfunction (CCD) is a progressive syndrome recognized in mature to aged dogs with a variety of neuropathological changes similar to human Alzheimer's disease (AD), for which it is thought to be a good natural model. However, the presence of hyperphosphorylated tau protein (p-Tau) in dogs with CCD has only been demonstrated infrequently. The aim of the present study was to investigate the presence of p-Tau and amyloid-β oligomer (Aβo) in cerebral cortex and hippocampus of dogs with CCD, with focus on an epitope retrieval protocol to unmask p-Tau. Immunohistochemical and immunofluorescence analysis of the cortical and hippocampal regions of five CCD-affected and two nondemented aged dogs using 4G8 anti-Aβp, anti-Aβ The extracellular Aβ senile plaques were of the diffuse type which lack the dense core normally seen in human AD. While p-Tau deposits displayed a widespread pattern and closely resembled the typical human neuropathology, they did not co-localize with the Aβp. Of considerable interest, however, widespread intraneuronal deposition of Aβ Taken together, these findings reveal further shared neuropathologic features of AD and CCD, supporting the case that aged dogs afflicted with CCD offer a relevant model for investigating human AD.

Sections du résumé

BACKGROUND BACKGROUND
Canine cognitive dysfunction (CCD) is a progressive syndrome recognized in mature to aged dogs with a variety of neuropathological changes similar to human Alzheimer's disease (AD), for which it is thought to be a good natural model. However, the presence of hyperphosphorylated tau protein (p-Tau) in dogs with CCD has only been demonstrated infrequently.
OBJECTIVE OBJECTIVE
The aim of the present study was to investigate the presence of p-Tau and amyloid-β oligomer (Aβo) in cerebral cortex and hippocampus of dogs with CCD, with focus on an epitope retrieval protocol to unmask p-Tau.
METHODS METHODS
Immunohistochemical and immunofluorescence analysis of the cortical and hippocampal regions of five CCD-affected and two nondemented aged dogs using 4G8 anti-Aβp, anti-Aβ
RESULTS RESULTS
The extracellular Aβ senile plaques were of the diffuse type which lack the dense core normally seen in human AD. While p-Tau deposits displayed a widespread pattern and closely resembled the typical human neuropathology, they did not co-localize with the Aβp. Of considerable interest, however, widespread intraneuronal deposition of Aβ
CONCLUSION CONCLUSIONS
Taken together, these findings reveal further shared neuropathologic features of AD and CCD, supporting the case that aged dogs afflicted with CCD offer a relevant model for investigating human AD.

Identifiants

pubmed: 34870101
doi: 10.3233/ADR-210035
pii: ADR210035
pmc: PMC8609497
doi:

Types de publication

Journal Article

Langues

eng

Pagination

749-760

Informations de copyright

© 2021 – The authors. Published by IOS Press.

Déclaration de conflit d'intérêts

The authors have no conflict of interest to report.

Références

Alzheimers Res Ther. 2019 Oct 18;11(1):86
pubmed: 31627745
Front Vet Sci. 2018 Aug 23;5:200
pubmed: 30191153
Front Aging Neurosci. 2018 Jan 30;10:7
pubmed: 29441010
Vet J. 2011 Jun;188(3):331-6
pubmed: 20542455
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Mar;29(3):389-97
pubmed: 15795047
Science. 2003 Apr 18;300(5618):486-9
pubmed: 12702875
Comp Cogn Behav Rev. 2016;11:63-82
pubmed: 29456781
Neurobiol Aging. 2000 Jan-Feb;21(1):89-96
pubmed: 10794853
Vet Pathol. 2016 Jan;53(1):7-9
pubmed: 26712813
Brain Pathol. 2021 Jan;31(1):144-162
pubmed: 32810333
Am J Pathol. 2017 Jul;187(7):1601-1612
pubmed: 28500862
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189
pubmed: 22229116
J Comp Neurol. 2008 Sep 1;510(1):79-99
pubmed: 18613121
Amyloid. 2001 Mar;8(1):11-21
pubmed: 11293821
J Vet Med Sci. 2016 Jul 1;78(6):997-1006
pubmed: 26922972
Vet Pathol. 2016 Mar;53(2):327-48
pubmed: 26869150
Mt Sinai J Med. 2010 Jan-Feb;77(1):32-42
pubmed: 20101720
J Alzheimers Dis. 2010;20(2):637-46
pubmed: 20164551
Acta Neuropathol Commun. 2015 Dec 10;3:78
pubmed: 26651821
Acta Neuropathol. 2017 Feb;133(2):155-175
pubmed: 28025715
J Alzheimers Dis. 2013;36(2):285-95
pubmed: 23594602
Alzheimers Res Ther. 2014 Jul 03;6(4):37
pubmed: 25024750
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
pubmed: 17245412
Curr Alzheimer Res. 2009 Apr;6(2):171-8
pubmed: 19355852
J Alzheimers Dis. 2015;47(4):815-43
pubmed: 26401762
J Neuropathol Exp Neurol. 2015 Sep;74(9):912-23
pubmed: 26247394
J Prev Alzheimers Dis. 2020;7(1):29-36
pubmed: 32010923
Alzheimers Dement (Amst). 2021 May 06;13(1):e12193
pubmed: 33977118
Neurobiol Learn Mem. 1996 Jul;66(1):11-23
pubmed: 8661247
J Alzheimers Dis. 2020;76(3):1135-1150
pubmed: 32597800
Am J Pathol. 2016 Jan;186(1):185-98
pubmed: 26718979
Acta Neuropathol. 2015 Feb;129(2):183-206
pubmed: 25604547
Int J Mol Sci. 2019 Apr 03;20(7):
pubmed: 30987146
Neurobiol Aging. 1996 Mar-Apr;17(2):259-68
pubmed: 8744407
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
Biochim Biophys Acta. 2013 Sep;1832(9):1384-9
pubmed: 23528711
J Neuroimmunol. 2014 Jul 15;272(1-2):76-85
pubmed: 24864011
Neurobiol Learn Mem. 2006 Sep;86(2):197-204
pubmed: 16616528
Brain. 2013 May;136(Pt 5):1383-98
pubmed: 23576130
J Comp Neurol. 2016 Mar 1;524(4):874-95
pubmed: 26239295
Curr Pharm Des. 2012;18(8):1131-47
pubmed: 22288400
Mol Neurodegener. 2019 Aug 2;14(1):32
pubmed: 31375134
Brain Res. 2006 Jan 19;1069(1):216-26
pubmed: 16423332
J Alzheimers Dis. 2016 Jul 14;53(4):1641-52
pubmed: 27540968
Prog Neuropsychopharmacol Biol Psychiatry. 2000 Jul;24(5):675-92
pubmed: 11191708
Res Vet Sci. 2007 Apr;82(2):208-14
pubmed: 16919689
Acta Neuropathol. 2006 Aug;112(2):175-83
pubmed: 16775693
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879

Auteurs

Umma Habiba (U)

School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.

Makiko Ozawa (M)

Department of Veterinary Pathology, the University of Tokyo, Japan.

James K Chambers (JK)

Department of Veterinary Pathology, the University of Tokyo, Japan.

Kazuyuki Uchida (K)

Department of Veterinary Pathology, the University of Tokyo, Japan.

Joseph Descallar (J)

Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia.

Hiroyuki Nakayama (H)

Department of Veterinary Pathology, the University of Tokyo, Japan.

Brian A Summers (BA)

School of Veterinary Medicine, Melbourne University, Werribee, Victoria, Australia.

John W Morley (JW)

School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.

Mourad Tayebi (M)

School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.

Classifications MeSH